These results suggested that myeloid cells were activated during the processes of ESCC tumorigenesis, resulting in an inflammatory microenvironment and CD8+ T-associated adaptive immune suppression, which might allow initiated ESCC cells to survive and proliferate. Here, CD8A is linked to esophageal squamous cell carcinoma.